Bank Of Montreal Puma Biotechnology, Inc. Transaction History

Bank Of Montreal

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.92 - $5.83 $109,640 - $218,904	-37,548 Reduced 34.8%	70,352 $229,000
Q1 2024 May 13, 2024	BUY	$4.29 - $7.4 $113,685 - $196,100	26,500 Added 32.56%	107,900 $571,000
Q4 2023 Feb 08, 2024	BUY	$2.23 - $4.49 $181,522 - $365,486	81,400 New	81,400 $352,000
Q4 2022 Feb 01, 2023	BUY	$2.12 - $5.08 $68,401 - $163,906	32,265 New	32,265 $136,000
Q1 2022 May 12, 2022	SELL	$2.13 - $3.24 $1.19 Million - $1.81 Million	-557,538 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$2.85 - $6.58 $867,753 - $2 Million	304,475 Added 120.32%	557,538 $1.82 Million
Q3 2021 Nov 12, 2021	SELL	$6.63 - $9.39 $67,818 - $96,050	-10,229 Reduced 3.89%	253,063 $1.85 Million
Q2 2021 Aug 12, 2021	BUY	$8.98 - $11.6 $2.36 Million - $3.05 Million	263,292 New	263,292 $2.58 Million

110

28.3M

27.9K

3.4K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $155M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.